Biomedical subjects

E Aguado

Publications and source records attributed to E Aguado.

26 records · Page 2Linked to original sources

PubMed1999

A new injectable calcium phosphate biomaterial for immediate bone filling of extraction sockets: a preliminary study in dogs.

BACKGROUND: Many different bone substitutes, such as autografts, allografts or synthetic biomaterials have been proposed to restore alveolar bone loss and support efficient placement of dental implants. This experimental study evaluated the osteoconductive properties of an injectable bone substitute (IBS) composed of a polymeric carrier and a calcium phosphate mineral phase, used to fill mandibular and maxillary canine extraction sockets. METHODS: The polymer was a cellulose derivative (methyl-hydroxy-propyl-cellulose, MHPC), and the mineral phase consisted of granules of biphasic calcium phosphate (BCP) ceramics 200 to 500 microm in diameter. Mandibular and maxillary premolars extracted from 3 dogs (a total of 60 extraction sites) were immediately treated with the IBS or left unfilled as control sites. Animals were sacrificed 3 months after implantation and all extraction sockets were prepared for histological evaluation. RESULTS: Qualitative histological studies showed that the IBS was able to support the extensive apposition of well-mineralized newly formed lamellar bone over the entire socket surface and appeared to prevent alveolar ridge bone loss in treated extraction sites. Quantitative evaluation showed that the amount of newly formed bone was significantly higher in mandibular than maxillary extraction sockets for both treated and control sites. CONCLUSIONS: An injectable bone substitute composed of a polymeric carrier and calcium phosphate was effective in enhancing the bone fill of extraction sockets. This approach may prove promising for periodontal lesions. The material expressed osteoconductive capacities, and the biological properties of the mineral phase were conserved.

Animals↗

PubMed1998

Growth hormone-loaded macroporous calcium phosphate ceramic: in vitro biopharmaceutical characterization and preliminary in vivo study.

Calcium phosphate ceramics recently have been used for administering therapeutic agents in bone. The present work investigated the efficacy of macroporous biphasic calcium phosphate (MBCP) implants as a matrix for local delivery of human growth hormone (hGH). An initial study showed that the release of 5 microg of hGH loaded onto MBCP cylinders was rapid during the first 48 h and sustained for a total of 11 days. The biological integrity of hGH (88.2%) was checked using a specific bioassay (cellular proliferation of hGH-sensitive Nb2 cells) in comparison with a radioimmunoassay to calculate the proportion of bioactive hGH released. MBCP cylinders then were loaded with 1, 10, and 100 microg of hGH and implanted into rabbit femurs (n = 16) to determine hGH effects on bone ingrowth and ceramic resorption, as evaluated by scanning electron microscopy and image analysis. Results indicated that hGH increased bone ingrowth and ceramic resorption significantly in comparison with contralateral and control implants. Biochemical parameters monitored in rabbit plasma showed that hGH did not produce detectable systemic effects. Thus the use of MBCP appears to be effective for local delivery of hGH and for increasing bone ingrowth.

Absorption↗

PubMed1998

Ultrastructural and electron diffraction of the bone-ceramic interfacial zone in coral and biphasic CaP implants.

We investigated the influence of natural coral implants used as a bone substitute on the quality of bone ingrowth in rabbits 2, 3, and 6 weeks after implantation. Explants were characterized by transmission electron microscopy and electron diffraction. Bone ingrowth has been previously demonstrated by light microscopy, however, few have been performed in electron microscopy to compare mineralized tissue ingrowth in coral implants which occurs at the expense of calcium carbonate to that of calcium phosphate (CaP) implants. The interface between coral aragonite and mineralized tissue or bone was abrupt, with no invasion of the aragonite structure by newly formed crystals, as occurs in micropores when biphasic CaP (BCP) ceramics were used. The restoring process appears to be different from that induced by BCP implants. Precipitation of needle-like apatite crystals on the CaCO3 implant surface was not observed. Instead, apatitic smooth-shaped crystals formed in aggregates. The coral dissolution process does not release phosphate and so precipitation of apatite does not occur in the micropores of the coral implant, thereby limiting the formation of an apatite layer and hence bone bonding to the outer surface of the implant. In addition, on the outer surface of the implant, close to bone and a phosphorus source, the CaP crystals that do form are in aggregates presumably due to the carbonate and mismatch between the aragonite and the apatite. This seems to result in a delayed bone attachment or weaker bone bonding than CaP implants which encourage an epitaxial biological crystal deposition.

Animals↗

PubMed1998

Human growth hormone locally released in bone sites by calcium-phosphate biomaterial stimulates ceramic bone substitution without systemic effects: a rabbit study.

Calcium-phosphate bone replacement biomaterial has been used as a drug carrier for therapeutic agents. This study investigated the efficacy of local administration of human growth hormone (hGH) by macroporous biphasic calcium phosphate (MBCP) implants in improving the bone substitution qualities of ceramics. hGH release from MBCP implants loaded with 1 microg of hGH was rapid during the first 48 h and then sustained for a total of 9 days. Immunolocalization of hGH in vitro and in vivo by transmission electron microscopy showed its presence inside the material, indicating that it was able to penetrate within the porosity of the ceramic during the adsorption process. MBCP cylinders (6 x 6 mm) were loaded with 0.1, 1, and 10 microg of hGH and implanted into rabbit femurs (n = 40). The effects of locally released hGH on bone ingrowth and ceramic resorption were evaluated by scanning electron microscopy and image analysis. The results indicated that hGH increased bone ingrowth (+65%) and ceramic resorption (+140%) significantly in comparison with control implants and that the increase was dose dependent. Biochemical parameters monitored in rabbit plasma and urine, as well as the absence of any significant difference between contralateral implants and the control, indicated that hGH did not produce detectable systemic effects. Thus, the use of MBCP appears to be effective for local delivery of hGH, resulting in improved bone substitution.

Animals↗

PubMed1997

Influence of local environment on incorporation of ceramic for lumbar fusion. Comparison of laminar and intertransverse sites in a canine model.

OBJECTIVES: To evaluate bone growth into macroporous ceramic in a canine model in terms of the effect at the lumbar spine site (lamina versus transverse process site) and the depth of the area within the ceramic block (peripheral or central areas). SUMMARY OF BACKGROUND DATA: Previous comparative studies have assessed that the efficacy of bone graft substitutes for spine fusion depends on their physicochemical properties and on the mechanical environment, but rarely on the grafting site at the lumbar spine level. METHODS: Posterior and lateral arthrodesis using pedicular instrumentation was performed at L2, L3, and L4 with a parallelepipedic ceramic block in an experimental group of dogs. A second group of dogs was fused with only autogenous bone graft to compare the fusion stiffness obtained with this material with the stiffness obtained with ceramic. Dogs were studied for 9 months. A biomechanical test and histomorphometric analysis were conducted. RESULTS: With the biomechanical test, no significant differences were found between ceramic and autogenous bone. The percentage of newly formed bone was higher (P < 0.0001) at the lamina (26.52 +/- 6.45%) than at the transverse process site (17.33 +/- 2.54%). For both locations, the highest amount of newly formed bone was observed in the area of close contact between ceramic and bone, and the lowest was observed in central areas (24.6 +/- 5.9% for the laminar site, 14.79 +/- 1.75% for the transverse process site). CONCLUSION: This animal study, which replicated the human procedure in posterolateral lumbar fusion, showed a significant difference of ceramic incorporation between laminar and intertransverse sites. This histomorphometric analysis also confirmed the relationship between bone in-growth and ceramic thickness and ceramic contact area with bone.

Animals↗

PubMedDate not supplied

Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth.

A total of 60 cylindrical 6 x 6 mm samples of a macroporous biphasic calcium phosphate (MBCP) ceramic were implanted into a distal femoral site in 30 rabbits. These samples represented six kinds of implants with two different macropore diameters and three different macroporosity percentages. Analysis of backscattered electron images of implant surfaces analysed by a factorial design method showed that implants with 565 microm pore size provided more abundant newly formed bone both in peripheral and deep pores than those with 300 microm pore size. No significant differences were found between implants with 40 and 50% macroporosity, suggesting that the influence of macropore size on bone ingrowth was greater than that of macroporosity percentage. MBCP implants with 565 microm pore diameter and 40% macroporosity represented the optimal association for homogeneous and abundant bone ingrowth.

Animals↗

PubMedDate not supplied

Enhanced bone integration of implants with increased surface roughness: a long term study in the sheep.

OBJECTIVES: This study evaluated the quality and the remodeling of bone around commercially pure titanium implants after 3, 6, 12 and 18 month implantation periods in the sheep. METHODS: Twelve animals were implanted in the cortico-trabecular areas of both femurs. Each femur received four implants with a rough surface (type 1) in the right femur and four with a smooth surface (type 2) in the left one. Bone blocks containing the implants were studied by histomorphometry on undecalcified specimens. The amount of bone around implants was measured (bone volume, fractional woven bone volume, bone thickness, contact interface) together with osteoblastic activity (mineral apposition rates, bone formation rates) and resorption activity (eroded surfaces). RESULTS: No significant differences could be observed for the two types of implants between 3 and 6 months. At 12 and 18 months, bone volume and contact interface were still increasing and there was always a tendency for type 1 implants to be associated with higher values. On the contrary, mineral apposition rate, bone formation rates and eroded surfaces decreased in the referent area in contact with the implant; this phenomenon of 'return to the normal' was more evident with type 1 implants. The remodeling process appears to increase bone quality and bone-titanium interface around implants in long term periods. CONCLUSIONS: The net bone quantity necessary to immobilize implants is obtained rapidly but the adapting process to mechanical strength can lead to a small but persistent increase in bone volume around implants. Although the differences between type 1 and type 2 implants were often small or statistically insignificant, the rougher type 1 implants seemed to be associated with stronger bone response.

Adaptation, Physiological↗

PubMedDate not supplied

The early remodeling phases around titanium implants: a histomorphometric assessment of bone quality in a 3- and 6-month study in sheep.

The purpose of this study was to evaluate the quality of the bone matrix around commercially pure titanium implants at 3 and 6 months postplacement in sheep. Implants were placed in the corticotrabecular areas of both femurs in 6 animals. Each animal received 4 Euroteknika implants in the right femur and 4 Nobel Biocare implants in the left femur. Bone blocks containing the implants were studied undecalcified after being embedded in methylmethacrylate. Sections were stained with toluidine blue and basic fuchsin. The amount of bone around the implants, the contact interface between the implant and bone, and the mineral apposition rates were measured. The fractional amount of woven bone could be quantified because of its high glycosaminoglycan content. No differences could be observed between the 2 types of implants. Total bone volume did not increase around both types of implants between 3 and 6 months, indicating that ankylosis was rapidly achieved. In contrast, in the area in contact with the implant, the bone-titanium interface drastically increased and the mineral apposition rate decreased. The fractional volume of woven bone around implants was considerably reduced after 6 months. Bone quality around implants was improved at 6 months (volume of woven bone near zero), and true osteonic structures were observed in close contact with titanium. The remodeling process appeared to improve bone quality and increase the bone-titanium interface around implants, while the net bone quantity necessary to immobilize implants was achieved rapidly and remained unchanged.

Animals↗